Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects
Abstract
The clinical study will assess the safety, tolerability, and immunogenicity of mRNA-1325 in healthy adult subjects. Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Participant, Investigator
Primary Purpose: Prevention
Official Title: A Phase 1/2, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of mRNA 1325 Zika Vaccine in Healthy Adults in a Non-endemic Zika Region